webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

BCN-PEG4-Ts

  CAS No.:   Cat No.: BADC-01230   Purity: ≥95% 4.5  

BCN-PEG4-Ts is a tosylate-activated ADC linker with BCN for strain-promoted cycloaddition and reactive tosyl group for nucleophilic substitution, suitable for site-specific antibody conjugation.

BCN-PEG4-Ts

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C26H37NO8S
Molecular Weight
523.64
Shipping
Room temperature
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Solubility
10 mm in DMSO
Shelf Life
≥ 2 years
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.

BCN-PEG4-Ts is a versatile bifunctional linker that finds extensive use in chemical biology and bioconjugation applications. Here are some key applications of BCN-PEG4-Ts:

Click Chemistry: BCN-PEG4-Ts is frequently used in click chemistry reactions to facilitate the efficient and selective coupling of biomolecules. By reacting with azide-functionalized compounds, it forms stable triazole linkages. This methodology is pivotal in creating complex bioconjugates for imaging, drug delivery, and diagnostic applications.

Protein Labeling: BCN-PEG4-Ts is employed to covalently modify proteins, enabling the attachment of various probes and functional groups. This application is crucial for studying protein interactions, tracking cellular localization, and monitoring protein dynamics in real time. The PEG4 spacer in BCN-PEG4-Ts reduces steric hindrance and enhances solubility, improving the labeling efficiency and stability of protein–probe conjugates.

Drug Delivery Systems: BCN-PEG4-Ts can be used to develop advanced drug delivery systems by conjugating therapeutic agents to polymers, nanoparticles, or other carrier molecules. This conjugation facilitates targeted delivery and controlled release of drugs to specific tissues or cells. The biocompatibility and stability of BCN-PEG4-Ts ensure safety and efficacy in therapeutic applications.

Surface Functionalization: BCN-PEG4-Ts is utilized to functionalize surfaces of materials such as nanoparticles, hydrogels, and biosensors with desired biomolecules or chemical groups. This surface modification enhances the specificity and sensitivity of biosensors and improves the biocompatibility of medical devices. The robust and stable linkages formed via BCN-PEG4-Ts ensure long-lasting and reliable surface coatings for various biotechnological applications.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mal-Phe-C4-Val-Cit-PAB | Methotrexate-d3 | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate | Biotin-sar-oh | DBCO-Peg4-VC-PAB-MMAE | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate | DBCO-PEG4-DBCO | BCN-PEG4-Ts
Send Inquiry
Verification code
Inquiry Basket